Use and safety of high-dose ifosfamide
Holoye, P.Y.; Anderson, T.; Duelge, J.; Hansen, R.M.; Ritch, P.S.
Seminars in Oncology 9(4 Suppl 1: 78-86
1982
ISSN/ISBN: 0093-7754 PMID: 6298946 Document Number: 189081
Document emailed within 1 workday
Related Documents
Yalcin, B.; Pamir, A.; Buyukcelik, A.; Utkan, G.; Akbulut, H.; Demirkazik, A.; Icli, F. 2004: High-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas Experimental Oncology 26(4): 320-325Scarfone, G.; Villa, A.; Parazzini, F.; Sciatta, C.; Polverino, G.; Bolis, G. 1999: A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy Tumori 85(4): 217-219
Chevallier, B. 1990: Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. the Granisetron Study Group European Journal of Cancer 26(Suppl 1): S33-S36
Lala, A.; Berger, J.S. 2011: Percutaneous coronary intervention for acute coronary syndromes: no difference in 30-day efficacy or safety of high- and low-dose aspirin; double-dose clopidogrel reduces 30-day risk of cardiovascular death, myocardial infarction or stroke compared with standard dose but increases risk of major bleeding Evidence-Based Medicine 16(3): 80-81
Durongpisitkul, K.; Pornrattanarungsi, S.; Panjasamanvong, P.; Chungsomprasong, P. 2011: Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension Journal of the Medical Association of Thailand 94(4): 421-426
Rakita, L.; Sobol, S.M. 1983: Amiodarone in the treatment of refractory ventricular arrhythmias. Importance and safety of initial high-dose therapy JAMA 250(10): 1293-1295
Nesvold, A.; Kontny, F.; Abildgaard, U.; Dale, J. 1991: Safety of high doses of low molecular weight heparin (Fragmin) in acute myocardial infarction. a dose-finding study Thrombosis Research 64(5): 579-587
Rodriguez, V.; Bodey, G.P.; Freireich, E.J.; McCredie, K.B.; McKelvey, E.M.; Tashima, C.K. 1976: Reduction of ifosfamide toxicity using dose fractionation Cancer Research 36(8): 2945-2948
Capizzi, R.L.; Powell, B.L. 1987: Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias Seminars in Oncology 14(2 Suppl 1: 40-50
Arlin, Z.A.; Feldman, E.J.; Finger, L.R.; Ahmed, T.; Mittelman, A.; Cook, P.; Puccio, C.; Baskind, P.; Arnold, P.; Razis, E.D. 1991: Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia Leukemia 5(8): 712-714
Passe, P.; Delepine, N.; Arnaud, P.; Urien, S.; Delepine, G.; Traoré, F.; Desbois, J.C.; Brion, F. 1999: Pharmacokinetic modelling of ifosfamide administered by continuous infusion on 5 days at the dose of 6 g/m2 Anticancer Research 19(1B): 837-842
Ohtake, T.; Yasuda, M.; Watanabe, K.; Ito, T.; Ito, J.; Miyamoto, K.; Yoshida, S.; Abe, N.; Ishigame, T.; Ishii, M.; Kimijima, I.; Takenoshita, S. 2009: Efficacy and safety of high-dose toremifene for hormone-responsive advanced or metastatic breast cancer patients with failed prior treatment by aromatase inhibitors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1459-1463
Comandone, A.; Bretti, S.; Bertetto, O.; Oliva, C.; Bergnolo, P.; Bumma, C. 2000: Low dose adriamycin and ifosfamide in the treatment of advanced adult soft tissue sarcomas Anticancer Research 20(3b): 2077-2080
Schmoll, H.J.; Bokemeyer, C.; Harstrick, A.; Illiger, H.J.; Metzner, B.; Ruther, U.; Osternamm, A.; Preiss, J.; Wilke, H.; Hohnloser, J. 1992: Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors Pathologie-Biologie 39(9): 961
Kanamori, M.; Kumabe, T.; Saito, R.; Yamashita, Y.; Sonoda, Y.; Tominaga, T. 2010: The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases No Shinkei Geka. Neurological Surgery 38(11): 997-1005
Palackdharry, C.S.; Krigel, R.L. 1994: Dose-intensive ifosfamide/carboplatin/etoposide plus granulocyte-macrophage colony-stimulating factor for non-small cell lung cancer Seminars in Oncology 21(3 Suppl 4: 6-11
Donato, M.L.; Champlin, R.E.; Wharton, J.T.; Bodurka-Bevers, D.; Gershenson, D. 2000: Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer European Journal of Gynaecological Oncology 21(3): 241-244
Cosmas, C.; Tsavaris, N.; Malamos, N.; Tsakonas, G.; Gassiamis, A.; Skopelitis, H.; Soukouli, G.; Polyzos, A.; Mylonakis, N.; Karabelis, A. 2005: Dose escalation of docetaxel and ifosfamide in patients with advanced breast cancer failing prior anthracyclines: mature results of a phase I-Ii study Journal of Buon: Official Journal of the Balkan Union of Oncology 10(3): 337-346
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Wheeler, R.H.; Ensminger, W.D.; Thrall, J.H.; Anderson, J.L. 1982: High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia Cancer Treatment Reports 66(3): 493-498